June JAAD: Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis Hidradenitis Suppurativa Foundations
Jun 1, 2022
Episode Description
Suiting Ao, MD and Wang Fang, MD interviewed by Steven Chen, MD, FAAD
Proudly Supported by
